<!DOCTYPE html>
<html>
    <head>
        <title>27</title>

    </head>
    <body>
        <div data-role="page" id="c27-t" data-theme="a">
            <div data-id="quickpick-header" data-role="header" data-theme="b" data-position="fixed"><a href="c25-clv.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h1>Condition Quick Pick</h1>
        <a href="../menu.html" class="ui-btn ui-icon-grid ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>    </div>
            <div data-role="content" data-theme="a" >
                <div id=quickpick_breadcrumbs>
                
                        <a href="c0-clv.html" >Condition Quick Pick</a><span class="carrot"> > </span>
                        <a href="c25-clv.html" >Hepatitis</a><span class="carrot"> > </span>Hepatitis B
                </div>   <!-- end of quick pick breadcrumbs -->
                </br><h3 class="sgc-1" id="sigil_toc_id_352">
 Diagnosis
</h3>
<p>
 Diagnosis of acute or chronic HBV infection requires serologic testing (Table 4). Because HBsAg is present in both acute and chronic infection, the presence of IgM antibody to hepatitis B core antigen (IgM anti-HBc) is diagnostic of acute or recently acquired HBV infection. Antibody to HBsAg (anti-HBs) is produced after a resolved infection and is the only HBV antibody marker present after vaccination. The presence of HBsAg and total anti-HBc, with a negative test for IgM anti-HBc, indicates chronic HBV infection. The presence of anti-HBc alone might indicate a false-positive result or acute, resolved, or chronic infection.
</p>
<p>
</p>
<h3 class="sgc-1" id="sigil_toc_id_353">
 Treatment
</h3>
<p>
 No specific therapy is available for persons with acute hepatitis B; treatment is supportive. Persons with chronic HBV infection should be referred for evaluation to a physician&nbsp;experienced in the management of CLD. Therapeutic agents cleared by FDA for treatment of chronic hepatitis B can achieve sustained suppression of HBV replication and remission of liver disease in some persons. In addition, patients with chronic hepatitis B might benefit from screening to detect HCC at an early stage.
</p>

            <div data-role="footer" data-id="regimens-footer" data-position="fixed" class="tab_treatment">
                <div data-role="navbar" class="tab_icons" data-iconpos="left">
                    <ul>
                        <li><a href="#" class="ui-disabled" id="treat_inactive" data-theme="a" data-icon="custom">Treatments</a></li>
                        <li><a href="#" id="info_active" data-theme="b" class="ui-btn-active ui-state-persist" data-icon="custom">More Info</a></li>
                    </ul>
                </div>
            </div>

        </div>
    </div>
</body>
</html>
